Andrew I Geller

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Emergency Department

Loop Mediated Isothermal Amplification

Top Venues

Pharmacoepidemiology and drug safety

Annals of internal medicine

Public health reports (Washington, D.C. : 1974)

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention

This page only lists publications with an associated author ORCID identifier.

Publications

Isaac See, Allison Lale, Paige Marquez, Michael B Streiff, Allison P Wheeler, Naomi K Tepper, Emily Jane Woo, Karen R Broder, Kathryn M Edwards, Ruth Gallego, Andrew I Geller, Kelly A Jackson, Shashi Sharma, Kawsar R Talaat, Emmanuel B Walter, Imo J Akpan, Thomas L Ortel, Victor C Urrutia, Shannon C Walker, Jennifer C Yui, Tom T Shimabukuro, Adamma Mba-Jonas, John R Su, David K Shay
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. Annals of internal medicine 175 (4) (2022)
Andrew I Geller, Daniel C Ehlman, Maribeth C Lovegrove, Daniel S Budnitz
National estimates of emergency department visits for medication-related self-harm: United States, 2016-2019. Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention 28 (6) (2022)
Andrew I Geller, Daniel S Budnitz, Heather Dubendris, Radhika Gharpure, Minn Soe, Hsiu Wu, Elizabeth J Kalayil, Andrea L Benin, Suchita A Patel, Megan C Lindley, Ruth Link-Gelles
Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020-July 2021. Public health reports (Washington, D.C. : 1974) 137 (2) (2022)
Andrew I Geller, Ariane O Conrad, Nina J Weidle, Hina Mehta, Daniel S Budnitz, Nadine Shehab
Outpatient insulin-related adverse events due to mix-up errors: Findings from two national surveillance systems, United States, 2012-2017. Pharmacoepidemiology and drug safety 30 (5) (2021)
Andrew I Geller, Esther H Zhou, Daniel S Budnitz, Maribeth C Lovegrove, Gerald J Dal Pan
Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications. Pharmacoepidemiology and drug safety 29 (3) (2020)